American journal of veterinary research · 1999
Effect of timing and route of administration of furosemide on pulmonary hemorrhage and pulmonary arterial pressure in exercising thoroughbred racehorses.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lester G, Clark C, Rice B, Steible-Hartless C, Vetro-Widenhouse T
Аннотация
OBJECTIVES: To examine effect of pre-exercise administration of furosemide (FUR) on mean pulmonary arterial pressure (PAP) during work and RBC concentration in bronchoalveolar lavage fluid (BALF) collected 40 minutes after exercise.
ANIMALS: 10 adult Thoroughbreds.
PROCEDURE: A modified 10 X 10 crossover design comprising 10 horses during 10 weeks was used. Each horse received each of 5 treatments twice. Treatment structure included a control plus a 2 X 2 factorial and consisted of the following: A, control; B, FUR, 250 mg, IV, 30 minutes before exercise; C, FUR, 250 mg, IV, 240 minutes before exercise; D, FUR, 250 mg, nebulized, 30 minutes before exercise; and E, FUR, 250 mg, nebulized, 240 minutes before exercise. Mean PAP data were collected, and each horse, after a 500-m warm-up, was galloped at maximal speed for 1,600 m. BALF RBC concentration was determined by hemocytometer.
RESULTS: Interaction between treatment method and time of administration was significant (P = 0.04). Treatment B resulted in significantly (P = 0.01) lower BALF RBC concentration than did treatment C. Only BALF RBC count after treatment B was significantly lower than the control value. Horses that received FUR IV had significantly lower peak mean PAP than did those that received the drug by nebulization, regardless of administration time. Only treatment B resulted in peak mean PAP that was significantly lower than that of control. Exercise time was not influenced by treatment.
CONCLUSIONS: FUR, administered IV 30 minutes before exercise, significantly reduced peak mean PAP and BALF RBC concentration.
ANIMALS: 10 adult Thoroughbreds.
PROCEDURE: A modified 10 X 10 crossover design comprising 10 horses during 10 weeks was used. Each horse received each of 5 treatments twice. Treatment structure included a control plus a 2 X 2 factorial and consisted of the following: A, control; B, FUR, 250 mg, IV, 30 minutes before exercise; C, FUR, 250 mg, IV, 240 minutes before exercise; D, FUR, 250 mg, nebulized, 30 minutes before exercise; and E, FUR, 250 mg, nebulized, 240 minutes before exercise. Mean PAP data were collected, and each horse, after a 500-m warm-up, was galloped at maximal speed for 1,600 m. BALF RBC concentration was determined by hemocytometer.
RESULTS: Interaction between treatment method and time of administration was significant (P = 0.04). Treatment B resulted in significantly (P = 0.01) lower BALF RBC concentration than did treatment C. Only BALF RBC count after treatment B was significantly lower than the control value. Horses that received FUR IV had significantly lower peak mean PAP than did those that received the drug by nebulization, regardless of administration time. Only treatment B resulted in peak mean PAP that was significantly lower than that of control. Exercise time was not influenced by treatment.
CONCLUSIONS: FUR, administered IV 30 minutes before exercise, significantly reduced peak mean PAP and BALF RBC concentration.